Bank of New York Mellon’s Anixa Biosciences ANIX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$192K Sell
58,271
-474
-0.8% -$1.56K ﹤0.01% 3975
2025
Q1
$168K Sell
58,745
-1
-0% -$3 ﹤0.01% 3901
2024
Q4
$136K Buy
58,746
+1
+0% +$2 ﹤0.01% 3983
2024
Q3
$185K Sell
58,745
-14,305
-20% -$45.1K ﹤0.01% 3921
2024
Q2
$161K Sell
73,050
-14,000
-16% -$30.9K ﹤0.01% 3976
2024
Q1
$272K Sell
87,050
-9,604
-10% -$30K ﹤0.01% 3813
2023
Q4
$375K Buy
96,654
+57
+0.1% +$221 ﹤0.01% 3701
2023
Q3
$316K Sell
96,597
-805
-0.8% -$2.63K ﹤0.01% 3775
2023
Q2
$312K Sell
97,402
-216
-0.2% -$691 ﹤0.01% 3805
2023
Q1
$420K Hold
97,618
﹤0.01% 3575
2022
Q4
$415K Sell
97,618
-238
-0.2% -$1.01K ﹤0.01% 3641
2022
Q3
$481K Hold
97,856
﹤0.01% 3582
2022
Q2
$299K Sell
97,856
-796
-0.8% -$2.43K ﹤0.01% 3878
2022
Q1
$271K Hold
98,652
﹤0.01% 4069
2021
Q4
$293K Hold
98,652
﹤0.01% 4099
2021
Q3
$471K Buy
98,652
+55,350
+128% +$264K ﹤0.01% 3843
2021
Q2
$168K Sell
43,302
-7,640
-15% -$29.6K ﹤0.01% 4128
2021
Q1
$238K Sell
50,942
-1,027
-2% -$4.8K ﹤0.01% 3990
2020
Q4
$160K Buy
51,969
+12,588
+32% +$38.8K ﹤0.01% 4019
2020
Q3
$96K Hold
39,381
﹤0.01% 3957
2020
Q2
$121K Hold
39,381
﹤0.01% 3886
2020
Q1
$63K Sell
39,381
-1,581
-4% -$2.53K ﹤0.01% 3930
2019
Q4
$134K Buy
40,962
+1,204
+3% +$3.94K ﹤0.01% 3979
2019
Q3
$159K Hold
39,758
﹤0.01% 3938
2019
Q2
$144K Sell
39,758
-49
-0.1% -$177 ﹤0.01% 3969
2019
Q1
$180K Sell
39,807
-3,172
-7% -$14.3K ﹤0.01% 3897
2018
Q4
$169K Buy
42,979
+1,069
+3% +$4.2K ﹤0.01% 3875
2018
Q3
$194K Sell
41,910
-1,646
-4% -$7.62K ﹤0.01% 3932
2018
Q2
$132K Sell
43,556
-2,923
-6% -$8.86K ﹤0.01% 3961
2018
Q1
$178K Buy
46,479
+1,230
+3% +$4.71K ﹤0.01% 3944
2017
Q4
$107K Buy
+45,249
New +$107K ﹤0.01% 4066